Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With <scp>AQP4</scp> ‐ <scp>IgG</scp> + <scp>NMOSD</scp> Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group ( <scp>NEMOS</scp>

Age > 60 years and immunoglobulin serum levels during rituximab treatment may serve as predictors for infection and help to individualize treatment decisions in NMOSD.

Authors

Institutions

Publication Details

Journal
European Journal of Neurology
Published
2026-02-01
DOI
https://doi.org/10.1111/ene.70520
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4 ‐ IgG + NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group ( NEMOS

Insa Schiffmann, Katrin Giglhuber, Joachim Havla, Corinna Trebst et al.
European Journal of Neurology
Multiple Sclerosis Research Studies
article

Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4 ‐ IgG + NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group ( NEMOS

Insa Schiffmann, Katrin Giglhuber, Joachim Havla, Corinna Trebst, Thorleif Etgen, C Warnke, Mariella Herfurth, Ioannis Vardakas, Orhan Aktas, Charlotte Schubert, FrankA Hoffmann, Daniel W. Engels, Jasmin Naumann, Katinka Fischer, Tania Kümpfel, F. Then Bergh, Carolin Schwake, Klemens Ruprecht, Makbule Senel, Judith Bellmann‐Strobl, Brigitte Wildemann, Martin W. Hümmert, Matthias Grothe, Vivien Häußler, Marius Ringelstein, Patrick Schindler, Achim Berthele, Sven Jarius, Neuromyelitis Optica Study Group (NEMOS), Ilya Ayzenberg
article en

Abstract

Age > 60 years and immunoglobulin serum levels during rituximab treatment may serve as predictors for infection and help to individualize treatment decisions in NMOSD.

European Journal of NeurologyVol. 33(2)
Universität Hamburg (DE), Philipps University of Marburg (DE), University of Cologne (DE), Universität Ulm (DE), Max Delbrück Center (DE), Heidelberg University (DE), TUM Klinikum (DE), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), Universität Greifswald (DE), Humboldt-Universität zu Berlin (DE), Kreisklinik Trostberg (DE), Düsseldorf University Hospital (DE), Knappschaftsklinikum Saar (DE), University Medical Center Hamburg-Eppendorf (DE), KRH Klinikum Agnes Karll Laatzen (DE), St. Josef-Hospital (DE), Martha-Maria Hospital (DE), Institute of Neuroimmunology of the Slovak Academy of Sciences (SK), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Leipzig University (DE)
Amgen, Eli Lilly and Company, Sanofi, Biogen, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Celgene, Guthy-Jackson Charitable Foundation, CSL Behring, Arthur Arnstein Stiftung, Argenx, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Klaus Tschira Stiftung, Friedrich-Baur-Stiftung, Stiftung Charité, Ipsen, Gemeinsame Bundesausschuss, Grifols, Sanofi Genzyme, Bayer Vital
Openalex Percentile: Top 68%
Multiple Sclerosis Research Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.